111 related articles for article (PubMed ID: 24407741)
21. Pharmacist-provided rapid HIV testing in two community pharmacies.
Darin KM; Klepser ME; Klepser DE; Klepser SA; Reeves A; Young M; Scarsi KK
J Am Pharm Assoc (2003); 2015; 55(1):81-8. PubMed ID: 25415222
[TBL] [Abstract][Full Text] [Related]
22. Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases.
Gubbins PO; Klepser ME; Adams AJ; Jacobs DM; Percival KM; Tallman GB
J Public Health Manag Pract; 2017; 23(6):593-600. PubMed ID: 27997479
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of community pharmacists' experiences with cholesterol screening programs.
Jungnickel PW; Wisehart DA
J Am Pharm Assoc (Wash); 1997; NS37(6):640-6. PubMed ID: 9425793
[TBL] [Abstract][Full Text] [Related]
24. Patient care services in rural Minnesota community pharmacies.
Haag JD; Stratton TP
J Am Pharm Assoc (2003); 2010; 50(4):508-16. PubMed ID: 20621869
[TBL] [Abstract][Full Text] [Related]
25. The pharmacy screening project--an evaluation of pharmacy-based screening programmes.
Flobbe K; IJsselmuiden CB; Rheeder P; Gerber JJ; Lubbe M
S Afr Med J; 1999 Sep; 89(9):980-6. PubMed ID: 10554636
[TBL] [Abstract][Full Text] [Related]
26. A feasibility study of community pharmacists performing depression screening services.
O'Reilly CL; Wong E; Chen TF
Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
[TBL] [Abstract][Full Text] [Related]
27. The I-Tribe Community Pharmacy Practice Model: professional pharmacy unshackled.
Alston GL; Waitzman JA
J Am Pharm Assoc (2003); 2013; 53(2):163-71. PubMed ID: 23571624
[TBL] [Abstract][Full Text] [Related]
28. Market dynamics of community pharmacies in Minnesota.
Schommer JC; Singh RL; Cline RR; Hadsall RS
Res Social Adm Pharm; 2006 Sep; 2(3):347-58. PubMed ID: 17138519
[TBL] [Abstract][Full Text] [Related]
29. Provision of Clinical Preventive Services by Community Pharmacists.
Kelling SE; Rondon-Begazo A; DiPietro Mager NA; Murphy BL; Bright DR
Prev Chronic Dis; 2016 Oct; 13():E149. PubMed ID: 27788064
[TBL] [Abstract][Full Text] [Related]
30. Pharmacist initiation of postexposure doxycycline for Lyme disease prophylaxis.
Jackson AN; Orr KK; Bratberg JP; Silverblatt F
J Am Pharm Assoc (2003); 2014; 54(1):69-73. PubMed ID: 24407743
[TBL] [Abstract][Full Text] [Related]
31. Professional implications of the expansion of pharmacy-based medical clinics.
Farley JF; Devine JW; Hadsall RS
J Am Pharm Assoc (2003); 2007; 47(3):410-4. PubMed ID: 17510039
[TBL] [Abstract][Full Text] [Related]
32. Impact of pharmacist-led community bone mineral density screenings.
Summers KM; Brock TP
Ann Pharmacother; 2005 Feb; 39(2):243-8. PubMed ID: 15613465
[TBL] [Abstract][Full Text] [Related]
33. Perceptions of patients on Medicare Part D medication therapy management services.
Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
[TBL] [Abstract][Full Text] [Related]
34. Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States.
Weber NC; Klepser ME; Akers JM; Klepser DG; Adams AJ
Expert Rev Mol Diagn; 2016; 16(2):253-64. PubMed ID: 26560318
[TBL] [Abstract][Full Text] [Related]
35. Community pharmacist-directed point-of-care group A Streptococcus testing: Evaluation of a Canadian program.
Papastergiou J; Trieu CR; Saltmarche D; Diamantouros A
J Am Pharm Assoc (2003); 2018; 58(4):450-456. PubMed ID: 29681440
[TBL] [Abstract][Full Text] [Related]
36. Bedlam Community Health Clinic: a collaborative interdisciplinary health care service for the medically indigent.
Brahm NC; Palmer T; Williams T; Clancy G
J Am Pharm Assoc (2003); 2007; 47(3):398-403. PubMed ID: 17510037
[TBL] [Abstract][Full Text] [Related]
37. Integrating pharmacists into diverse diabetes care teams: implementation tactics from Project IMPACT: Diabetes.
Watson LL; Bluml BM
J Am Pharm Assoc (2003); 2014; 54(5):538-41. PubMed ID: 25216884
[TBL] [Abstract][Full Text] [Related]
38. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
[TBL] [Abstract][Full Text] [Related]
39. Pharmacist-led depression screening and intervention in an underserved, rural, and multi-ethnic diabetic population.
Wilson C; Twigg G
J Am Pharm Assoc (2003); 2018; 58(2):205-209. PubMed ID: 29217142
[TBL] [Abstract][Full Text] [Related]
40. Pharmaceutical care in community pharmacies: practice and research in the US.
Christensen DB; Farris KB
Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
